| NCT ID | NCT02264678 |
| Title | Ascending Doses of AZD6738 in Combination With Chemotherapy and/or Novel Anti Cancer Agents |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | yes |
| Sponsors | AstraZeneca |
| Indications |
gastroesophageal junction adenocarcinoma |
| Therapies | |
| Age Groups: | senior adult |